SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunex -- Ignore unavailable to you. Want to Upgrade?


To: SEAN007 who wrote (330)5/12/1999 9:36:00 PM
From: Arthur Radley  Respond to of 656
 
Quoting from the news release...." may increase the chance
of potentially life-threatening infections "

When did the word "may" become a definitive action or result in this case other than in your mind?....THEIR DRUG KILLED PEOPLE



To: SEAN007 who wrote (330)5/13/1999 2:40:00 AM
From: Roger Cranwill  Read Replies (2) | Respond to of 656
 
Oh, I think there's a response necessary, if you can hear me from your elevated plane of morality. These people took the drug VOLUNTARILY in the case of Enbrel to at least salvage some quality of life, in the case of Rituxan, as a last hope of retaining life. All-I'll say it again-ALL endeavors in life entail a statistical amount of risk-be it driving a car, going to the bathroom, and in the case of drug therapy-THERE IS NO SUCH THING AS THE IDEAL DRUG, one that only works for the specific indication without the element of risk. That 6 people died is indeed regrettable-that they had the courage to actively do something to try to better their condition is laudable.
As I said, in anything in life there is a certain amount of risk, so please be careful stepping down off that judgmental soapbox, you supercilious jerk!



To: SEAN007 who wrote (330)5/14/1999 2:56:00 AM
From: synchro  Respond to of 656
 
Sean007, what people are saying is that there's not yet a direct cause-and-effect link between Enbrel and the deaths. There simply need to be more long-term studies. The drug does directly modify the immune system, so I wouldn't be surprised if caution is needed in physicians applying the drug to patients, especially if their immune system is weak to start out. It is in the long-term interests of patients, shareholders, regulators and management that this drug is properly understood.

What we don't need is a hysterical reaction when nothing is proven yet. The drug has shown it made one hell (I mean heaven) of a difference in a lot of people's lives who have RA.

Btw, why are you here on this board anyway? People are here usually because they want to make profit, which in turn give them happiness in their lives.